Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




PWRM, AMLN, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and Amylin Pharmaceuticals, Inc.

Dr. Stock Pick (November 2nd, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday November 2, 2009

DrStockPick.com Stock Report!

PWRM, AMLN

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical

...
Tags for this Post:
advertisement services, ALS, AMLN, Amylin Pharmaceuticals Inc., Beijing, Biopharmaceutical, Breast Cancer, broker, Byetta, BYETTA® (exenatide) injection, cancer, Chair and Keynote Speaker, chief scientific officer, China, Congress, Crown Equity Holdings Inc.;, Diabetes, diagnostic tests, Dr Stock Pick, equity trader, Fda, Houston, International Congress, Investing Lessons, Ira Goldknopf, neurodegenerative disease;, obesity, Pharmaceutical Products, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, professional investment analyst and consultant, stock featured on our site;, Stock Pick, Stocks to Watch, Takeda Pharmaceutical Company Limited, Texas, treatment of obesity, U.S. Food and Drug Administration, USD, www.amylin.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

AMLN, TNUS, PSFT, DrStockPick.com Watch List! for Monday November 2nd, 2009, Amylin Pharmaceuticals Inc., Total Nutraceutical Solutions Inc. and PowerSafe Technology Corp.

Dr. Stock Pick (November 1st, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Picks for Monday November 2nd, 2009, are:

**************************************************************

AMLN, Amylin Pharmaceuticals, Inc.

AMLN is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines.

AMLN has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection.

The U.S. Food and Drug Administration (FDA) has approved an expanded indication for AMLN’s BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes. Previously, it was approved for

...
Tags for this Post:
advertisement services, AMLN, Amplification Technologies Inc., Amylin Pharmaceuticals Inc., Biopharmaceutical, broker, BYETTA® (exenatide) injection, chemical sensors, Crown Equity Holdings Inc.;, Diabetes, Dr Stock Pick, drug development, equity trader, Homeland Security, Investing Lessons, medical diagnostics, Model Biosystems Inc., obesity, Pharmaceutical Products, platform semiconductor, platform semiconductor technology, PowerSafe Technology Corp., professional investment analyst and consultant, scientific instrumentation, stock featured on our site;, Stock Pick, Stocks to Watch, Symlin, Takeda Pharmaceutical Company Limited, TNUS, Total Nutraceutical Solutions Inc., treatment of obesity, U.S. Food and Drug Administration, USD, www.amplificationtechnologies.com, www.amylin.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.stock-ir.com

AMLN, Green Light to FDA for Its BYETTA for Expanded Use as First-Line Treatment for Type 2 Diabetes. AMLN, X-Treme Hot Stock Alert by DrStockPick.com

Dr. Stock Pick (October 31st, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Saturday October 31, 2009

DrStockPick.com Stock Report!

**************************************************************

AMLN, Amylin Pharmaceuticals, Inc.

AMLN is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines.

AMLN has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection.

The U.S. Food and Drug Administration (FDA) has approved an expanded indication for AMLN’s BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type

...

AMLN, PWRM, MMM, CSRH, MYL, CVAT, STEM, AQNM, DrStockPick.com Stock Report!

Dr. Stock Pick (October 19th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday October 19, 2009

DrStockPick.com Stock Report!

AMLN, PWRM, MMM, CSRH, MYL, CVAT, STEM, AQNM

**************************************************************

AMLN, Amylin Pharmaceuticals, Inc.

AMLN is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines.

AMLN will webcast its Quarterly Update Conference Call for the third quarter of 2009 on Tuesday, October 20, 2009 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin’s president and chief executive officer, will lead the call. On the same date post-market, Amylin will release financial results for the third quarter of 2009.

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a

...
Tags for this Post:
3M Co., active pharmaceutical ingredients;, advertisement services, advertising services, ALS, AMLN, Amylin Pharmaceuticals Inc., Aquentium Inc.;, Beijing, beverage, Biopharmaceutical, Biotechnology, blindness, Breast Cancer, broker, California, cancer, Cavitation Technologies Inc., ceo, Chair and Keynote Speaker, Chatsworth, chemical industries, Chemicals, Chicago, chief scientific officer, China, Congress, Consorteum Holdings Inc.;, Crown Equity Holdings Inc.;, CSRH, CVAT, Daniel M. Bradbury, diagnostic tests, Director of Sales and Business Development, distinct technology platforms, diverse applications, Dr Stock Pick, drive-thru technology, drive-thru technology needs, e-coli, energy, Engineering Department, environmental friendly technology, equity trader, Far East, Fda, food, food restaurants, Food Safety, Gas Station, General Manager, generic pharmaceutical products, green technologies;, Houston, HyperActive Technologies, Illinois, India, International Congress, Investing Lessons, Ira Goldknopf, Japan, Kazushi Miyauchi, Kirk Wiggins, Koichi Takahagi, Korea, leader in the development, macular degeneration, malnutrition, Mark Taggatz;, mining, Miura Engineering Co. Ltd., Mylan Inc., Nano-Cavitation Process Systems, neurodegenerative disease;, neuroscience, non-chemical sanitation equipment, Ontario, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, President & COO, president and chief executive officer, professional investment analyst and consultant, Quent Rickerby;, real-time check cashing services, Roman Gordon, Shigeru Miura, Society for Neuroscience;, stem cell technologies, Stem Cells, StemCells Inc., stock featured on our site;, Stock Pick, Stocks to Watch, Texas, Tokyo, Toronto, United States, USD, vegetable oil refining, Waste To Energy, wastewater treatment, water treatment equipment, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.miura21.co.jp, www.power3medical.com, www.stock-ir.com

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.